Gene transfer of angiogenic growth factors with replicationdeficient recombinant adenovirus (Ad) vectors may provide a new approach to the treatment of ischemic diseases. To determine if Ad-infected cells could stimulate angiogenesis in vivo and to assess the tumorigenicity of cells infected with th
Role of fibroblasts and fibroblast-derived growth factors in periprosthetic angiogenesis
✍ Scribed by Miklos Tunyogi-Csapo; Tamas Koreny; Csaba Vermes; Jorge O. Galante; Joshua J. Jacobs; Tibor T. Glant
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 350 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0736-0266
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The periprosthetic granulomatous soft tissue [designated iterfacial membrane (IFM) in this study] exhibits heterogeneous histopathological features, in which highly vascularized areas with dense cellularity alternate with fibrotic and pseudocapsule‐like tissue structures. Although macrophage/monocyte activation is a prominent event in the periprosthetic environment, fibroblasts also phagocytose particulate wear debris both in vivo and in vitro. Particulate wear debris and/or cytokines/growth factors alone or in combination (e.g., in conditioned media of explant cultures of IFMs) stimulated normal synovial and IFM fibroblasts to express inflammatory mediators and growth factors such as interleukin (IL)‐1β, IL‐6, IL‐8, three isoforms of vascular endothelial growth factor (VEGF), monocyte/macrophage chemoattractant protein‐1 (MCP‐1), macrophage‐colony‐stimulating factor (M‐CSF), cycloxygenases (Cox‐1 and Cox‐2), acid‐ and basic‐fibroblast growth factors (FGF‐1 and FGF‐2), leukemia inhibitory factor‐1 (LIF‐1), transforming growth factor β‐1 (TGF‐β1), receptor activator of nuclear factor‐kappa B ligand (RANKL), and osteoprotegerin (OPG). Thus, the fibroblast is capable of expressing a wide array of angiogenic and osteoclastogenic factors which are involved in the detrimental processes of the periprosthetic osteolysis. © 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 25:1378–1388, 2007
📜 SIMILAR VOLUMES
Angiogenesis is a possible target in the treatment of human gliomas. To evaluate the role of 3 growth factors, vascular endothelial growth factor (VEGF), hepatocyte growth factor/scatter factor (HGF/SF) and basic fibroblast growth factor (bFGF), in the angiogenic cascade, we determined their levels
## Abstract The inner ear, which mediates hearing and equilibrium, develops from an ectodermal placode located adjacent to the developing hindbrain. Induction of the placode and its subsequent morphogenesis and differentiation into the inner ear epithelium and its sensory neurons, involves signalli
Substance P (SP), fibroblast growth factor (FCF), and epidermal growth factor (EGF) are mitogens for fibroblasts. EGF acts as a progression factor, whereas FGF and SP have competence factor activity. The ability of eicosanoids to regulate proliferation of fibroblasts and the increased production of
To study the relationship between androgen metabolism and the pathogenesis of benign prostatic hypertrophy, we purified a growth factor from benign hyperplastic tissue of human prostates and assayed the proliferative responses of human fetal prostatic fibroblasts to the purified growth factor (hPGF)